Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Growth responses during the first year of growth hormone therapy: evaluation of height velocity targets

Nature Clinical Practice Endocrinology & Metabolism volume 4, pages 258–259 (2008)Cite this article

boxed-textBakker B et al. (2008) Height velocity targets from the National Cooperative Growth Study for first-year growth hormone responses in short children. J Clin Endocrinol Metab 93: 352–357

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ranke MB et al (1999) Derivation and validation of a mathematical model for predicting the response to exogenous recombinant growth hormone (GH) in prebubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab 84: 1174–1183

    Article  CAS  Google Scholar 

  2. Schönau E et al. (2001) A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur J Endocrinol 144: 13–20

    Article  Google Scholar 

  3. de Ridder MA et al. (2007) Prediction of adult height in growth-hormone-treated children with growth hormone deficiency. J Clin Endocrinol Metab 92: 925–931

    Article  CAS  Google Scholar 

  4. Rosenbloom AL (1999) A mathematical model for predicting growth responses to growth hormone replacement therapy–a useful tool or an intellectual exercise? J Clin Endocrinol Metab 84: 1172–1173

    CAS  PubMed  Google Scholar 

  5. Cohen P et al. (2007) Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92: 2480–2486

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. 150 Lockwood Avenue, New Rochelle, NY 10801, USA phsaenger@aol.com

Authors and Affiliations

  1. P Saenger is a Professor of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA.,

    Paul Saenger

Authors
  1. Paul Saenger
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Dr Saenger is a consultant for Sandoz and a member of the Speaker's bureau for Eli Lilly, Genentech and Pfizer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saenger, P. Growth responses during the first year of growth hormone therapy: evaluation of height velocity targets. Nat Rev Endocrinol 4, 258–259 (2008). https://doi.org/10.1038/ncpendmet0792

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0792

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing